CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Avantium NV Company Snapshot
Avantium NV operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Avantium NV with three other miscellaneous service companies in Europe: Genoway of France (2018 sales of 10.80 million Euro [US$11.97 million] ), Ab-Biotics SA of Spain (11.89 million Euro [US$13.17 million] ), and Bioventix Plc which is based in the United Kingdom (£8.75 million [US$10.90 million] ).

Sales Analysis. During the year ended December of 2018, sales at Avantium NV were 11.28 million Euro (US$12.50 million). This is a decrease of 10.8% versus 2017, when the company's sales were 12.65 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Avantium NV
  Stock Performance Chart for Avantium NV
 
  Stock Data: Recent Stock Performance:
  Current Price (9/13/2019): 2.56
(Figures in Euro)
1 Week 1.0%   13 Weeks 0.4%  
4 Weeks 7.8%   52 Weeks -54.5%  
 
Avantium NV Key Data:
  Ticker: AVTX Country: Netherlands
  Exchanges: AMS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 11,283,000
(Year Ending Jan 2019).
Employees: 169
  Currency: Euro Market Cap: 66,000,292
  Fiscal Yr Ends: December Shares Outstanding: 25,831,817
  Share Type: Certificaten Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.